The Avastin Juggernaut: Transformation of the Age-Related Macular Degeneration Market
Topics: Antibody Technologies, Biotechnology, Pharmaceuticals, Gerontology/Aging, Ophthalmology
|
Next-Generation Biologics: Improving on Monoclonal Antibodies
Topics: Antibody Technologies, Biopharmaceuticals
|
Pipeline Insight: Molecular Targeted Cancer Therapies Can Anything Else Revolutionize The Market?
Topics: Emerging Technology, Antibody Technologies, Oncology/Hematology
|
Immunogenicity to Biologics
Topics: Proteomics, Research & Development, Antibody Technologies, Biotechnology, Research & Development, Biopharmaceuticals
|
Monoclonal Antibodies Report Part II: Companies - Holding mAbs in portfolio promises protection against the looming 2011-12 patent cliff
Topics: Antibody Technologies, Prescription Drugs
|
Monoclonal Antibodies Report Part I
Topics: Antibody Technologies
|
Monoclonal Antibodies Report Market Model
Topics: Antibody Technologies
|
Triple Analysis: Antibody Drug Target Atlas in Oncology and Special Focus on Leukemias and Lymphomas
Topics: Antibody Technologies, Oncology/Hematology
|
Antibody Drug Target Atlas in Oncology
Topics: Antibody Technologies, Oncology/Hematology
|
Triple Analysis: Antibody Drug Target Atlas in Oncology and Special Focus on Breast- and Prostate Cancer
Topics: Antibody Technologies, Oncology/Hematology
|
Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments: World Market
Topics: Antibody Technologies, Vaccines, Biopharmaceuticals, Oncology/Hematology
Regions: Global
|
China Antibodies
Topics: Antibody Technologies
Regions: China
|
Immunotherapy of Cancer
Topics: Antibody Technologies, Vaccines, Oncology/Hematology
|
Are Biologics the Wave of the Future?
Topics: Research & Development, Antibody Technologies, Biopharmaceuticals
|
2007 Antibody Report: Current Trends and Future Outlook
Topics: Antibody Technologies
|
Next Generation Protein Engineering and Drug Design: Strategies to boost efficacy and improve drug delivery
Topics: Research & Development, Antibody Technologies, Drug Discovery
|
Conference Documentation: Therapeutic Antibodies
Topics: Antibody Technologies
|
Monoclonal Antibody Therapy
Topics: Antibody Technologies
|
Monoclonal Antibody Therapies 2007: Competitive Landscape and Pipeline Insight
Topics: Antibody Technologies
|
Stakeholder Opinions: Respiratory Syncytial Virus (RSV) - A market yet to reach its full potential
Topics: Antibody Technologies, Infectious Diseases, Respiratory/Pulmonary
|
The Global Protein Therapeutics Market: Market Dynamics and Pipeline Analysis
Topics: Enzymes, Research & Development, Antibody Technologies
Regions: Global
|
Therapeutic Monoclonal Antibodies, 2006-2011 - Maximising the Growth Potential of a Stocked Pipeline
Topics: Antibody Technologies
|
Antibody Therapeutics: Product Development, Market Trends, and Strategic Issues (Revised Edition)
Topics: Emerging Technology, Antibody Technologies
|
Technology Developments in Functional Proteomics (Technical Insights)
Topics: Proteomics, Antibody Technologies, Diagnostics, Drug Discovery
|
Proteomics: Current State and Future Directions
Topics: Proteomics, Antibody Technologies, Drug Discovery
|
Triple Analysis: Melanoma Therapeutics, Antibodies and Vaccines in Oncology
Topics: Research & Development, Antibody Technologies, Vaccines, Oncology/Hematology
|
Protein and Antibody Microarray Markets
Topics: Research & Development, Antibody Technologies
|
The Future of Monoclonal Antibodies Therapeutics: Innovation In Antibody Engineering, Key Growth Strategies And Forecasts To 2011
Topics: Antibody Technologies, Biopharmaceuticals
|
Analytical Tool - The Commercial Success of Cancer Therapeutic Antibodies
Topics: Antibody Technologies, Oncology/Hematology
|
Chronic Lymphocytic Leukemia: Monoclonal Antibodies Will Drive Steady Growth
Topics: Antibody Technologies, Pharmaceuticals, Biopharmaceuticals, Oncology/Hematology
|
The Market for Antibodies: Keys to Success for Commercial Suppliers, Volume II
Topics: Antibody Technologies
|
The Protein Therapeutics Market: The Science and Business of a Growing Sector
Topics: Enzymes, Antibody Technologies, Biopharmaceuticals
|
Triple Progress Analysis: Lymphoma Therapeutics, Protein Kinase Inhibitors & Therapeutic Antibodies
Topics: Antibody Technologies
|
Conference Documentation: Therapeutic Antibodies
Topics: Antibody Technologies
|
Transgenic Animals and Plants in Pharmaceutical Research and Manufacturing
Topics: Antibody Technologies, Genetic Engineering, Manufacturing, Packaging & Detailing, Research & Development, Biopharmaceuticals
|
The Commercial Success of Cancer Therapeutic Antibodies - The Formation of a Second Wave
Topics: Antibody Technologies, Oncology/Hematology
|
Market Opportunities and Challenges for Antibody Arrays and Beads: A Market Research Study
Topics: Antibody Technologies
|
Antibody Technology Developments (Technical Insights)
Topics: Antibody Technologies
|
Antibodies 2005: Keys to Success in a Competitive Market
Topics: Antibody Technologies
|
Analysis Report on China's Antineoplastic Market
Topics: Antibody Technologies
Regions: China
|
Dynamic Antibody Industry
Topics: Antibody Technologies
|
U.S. Therapeutic Monoclonal Antibodies Markets
Topics: Antibody Technologies
Regions: United States
|
Monoclonal Antibody Therapeutics - Current Market Dynamics & Future Outlook
Topics: Antibody Technologies
Regions: Global
|
Monoclonal Antibody Therapies: Sector Analysis Tool
Topics: Antibody Technologies
|
Monoclonal Antibody Therapies: Evolving into a $30 billion market
Topics: Antibody Technologies
|
The European Monoclonal Antibodies Therapeutics Market
Topics: Antibody Technologies
Regions: Europe
|
Strategic Analysis of the Therapeutic Peptide Market in Europe
Topics: Antibody Technologies, Pharmaceuticals, Diseases & Conditions
Regions: Europe
|
New Directions in Monoclonal Antibodies: Technologies, Markets, Competition
Topics: Antibody Technologies
|
Antibody Therapeutics: Product Development, Market Trends, and Strategic Issues
Topics: Antibody Technologies
|
Monoclonal Antibodies in Cancer Therapy: Emerging Products and Markets
Topics: Antibody Technologies, Oncology/Hematology
|
